Am J Cancer Res 2012;2(2):214-221

Review Article
Bcl2:Beclin 1 complex: multiple mechanisms regulating autophagy/apoptosis
toggle switch

Rebecca T. Marquez, Liang Xu

University of Kansas, Department of Molecular Biosciences, Lawrence, Kansas, USA.

Received December 21, 2011; accepted January 6, 2012; Epub February 15, 2012; Published February 28, 2012

Abstract: Cancer cells have developed novel mechanisms for evading chemotherapy-induced apoptosis and autophagy-
associated cell death pathways.  Upon the discovery that chemotherapeutics could target these cell death pathways in a manner
that was not mutually exclusive, new discoveries about the interrelationship between these two pathways are emerging.  Key
proteins originally thought to be “autophagy-related proteins” are now found to be involved in either inducing or inhibiting
apoptosis.  Similarly, apoptosis inhibiting proteins can also block autophagy-associated cell death.  One example is the complex
formed by the autophagy protein, Beclin 1, and anti-apoptotic protein Bcl-2, which leads to inhibition of autophagy-associated cell
death.  Researchers have been investigating additional mechanisms that form/disrupt this complex in order to better design
chemotherapeutics.  This review will highlight the role Bcl-2 and Beclin 1 play in cancer development and drug resistance, as
well as the role the Bcl-2:Beclin 1 complex in the switch between autophagy and apoptosis. (AJCR0000098).

Keywords: Bcl2:Beclin 1 complex, autophagy/apoptosis, regulation, cancer. chemotherapy


Address all correspondence to:
Dr. Liang Xu
University of Kansas
Department of Molecular Biosciences
Lawrence, Kansas, USA.
E-mail: xul@ku.edu
AJCR Copyright © 2010-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA
American Journal of Cancer Research
ISSN: 2156-6976